General Court 26 January 2017, Case T-88/16: Judgment of the General Court of 26 January 2017 — Opko Ireland Global Holdings v EUIPO — Teva Pharmaceutical Industries (ALPHAREN) (EU trade mark — Opposition proceedings — Application for EU word mark ALPHAREN — Earlier national word marks ALPHA D3 — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 — Consideration of new evidence by the Board of Appeal following a judgment annulling a decision — Article 76(2) of Regulation No 207/2009)
Also known as
European Union · · · 26-01-2017
13.3.2017 EN Official Journal of the European Union C 78/29 Judgment of the General Court of 26 January 2017 — Opko Ireland Global Holdings v EUIPO — Teva Pharmaceutical Industries (ALPHAREN) (Case T-88/16) (1) ((EU trade mark - Opposition proceedings - Application for EU word mark ALPHAREN - Earlier national word marks ALPHA D3 - Relative ground for refusal - Likelihood of confusion - Article
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit